Phathom Pharmaceuticals (PHAT) EBIT Growth (3y) (2021 - 2026)
Phathom Pharmaceuticals (PHAT) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.78% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn | 19.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.87% |
| Dec 31, 2025 | 49.72% |
| Sep 30, 2025 | 28.92% |
| Jun 30, 2025 | -9.72% |
| Mar 31, 2025 | -27.66% |
| Dec 31, 2024 | -21.61% |
| Sep 30, 2024 | -28.79% |
| Jun 30, 2024 | -29.83% |
| Mar 31, 2024 | -27.71% |
| Dec 31, 2023 | -10.04% |
| Sep 30, 2023 | -2.79% |
| Jun 30, 2023 | -16.55% |
| Mar 31, 2023 | -13.86% |
| Dec 31, 2022 | -43.78% |
| Sep 30, 2022 | -89.17% |
| Jun 30, 2022 | 18.24% |
| Mar 31, 2022 | -213.86% |
| Dec 31, 2021 | -318.43% |